Search details
1.
Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation.
J Transl Med
; 14(1): 230, 2016 08 02.
Article
in English
| MEDLINE | ID: mdl-27484705
2.
Outcome of allogeneic transplantation in newly diagnosed and relapsed/refractory multiple myeloma: long-term follow-up in a single institution.
Eur J Haematol
; 97(5): 479-488, 2016 Nov.
Article
in English
| MEDLINE | ID: mdl-27028304
3.
γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs.
Blood
; 120(26): 5153-62, 2012 Dec 20.
Article
in English
| MEDLINE | ID: mdl-23018643
4.
Secondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma.
Haematologica
; 99(12): 1846-53, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25193963
5.
Tuberculosis-Associated Hemophagocytic Lymphohistiocytosis: Diagnostic Challenges and Determinants of Outcome.
Open Forum Infect Dis
; 11(4): ofad697, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38560612
6.
The influence of fixation and cryopreservation of cerebrospinal fluid on antigen expression and cell percentages by flow cytometric analysis.
Sci Rep
; 14(1): 2463, 2024 01 30.
Article
in English
| MEDLINE | ID: mdl-38291295
7.
Significant impact of antibiotic exposure on GI-GVHD, NRM, and GRFS following allogeneic HCT with non-myeloablative Flu-TBI conditioning.
Leuk Lymphoma
; : 1-8, 2024 Mar 23.
Article
in English
| MEDLINE | ID: mdl-38520720
8.
A difficult to treat Leishmania infantum relapse after allogeneic stem cell transplantation.
IDCases
; 32: e01753, 2023.
Article
in English
| MEDLINE | ID: mdl-37063784
9.
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities.
JCO Oncol Pract
; 19(3): e407-e416, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36508702
10.
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.
Cancers (Basel)
; 15(22)2023 Nov 16.
Article
in English
| MEDLINE | ID: mdl-38001703
11.
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
Cancers (Basel)
; 15(17)2023 Aug 30.
Article
in English
| MEDLINE | ID: mdl-37686611
12.
Histological assessment of the sclerotic graft-versus-host response in the humanized RAG2-/-γc-/- mouse model.
Biol Blood Marrow Transplant
; 18(7): 1023-35, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22579931
13.
Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT.
Bone Marrow Transplant
; 57(5): 817-823, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35332305
14.
Influence of donor cytomegalovirus (CMV) status on severity of viral reactivation after allogeneic stem cell transplantation in CMV-seropositive recipients.
Clin Infect Dis
; 52(7): e144-8, 2011 Apr 01.
Article
in English
| MEDLINE | ID: mdl-21427386
15.
Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909.
Cancer Immunol Immunother
; 60(2): 161-71, 2011 Feb.
Article
in English
| MEDLINE | ID: mdl-20963411
16.
The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study.
Haematologica
; 96(9): 1380-4, 2011 Sep.
Article
in English
| MEDLINE | ID: mdl-21546493
17.
Increasing ferritin predicts early death in adult hemophagocytic lymphohistiocytosis.
Int J Lab Hematol
; 43(5): 1024-1031, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-33595184
18.
Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCT.
Bone Marrow Transplant
; 56(11): 2651-2655, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34148060
19.
Rituximab treatment before reduced-intensity conditioning transplantation associates with a decreased incidence of extensive chronic GVHD.
Biol Blood Marrow Transplant
; 15(6): 671-8, 2009 Jun.
Article
in English
| MEDLINE | ID: mdl-19450751
20.
Modifying Graft-versus-Host Disease in a Humanized Mouse Model by Targeting Macrophages or B-Cells.
J Immunol Res
; 2019: 3538963, 2019.
Article
in English
| MEDLINE | ID: mdl-31205954